Last April in Cell, a research team led by Li-Huei Tsai showed that not only 40Hz light, but also exposure to 40Hz sound, can effectively increase gamma power and synchrony across the brain, reduce amyloid and tau buildup, and improve learning and memory in multiple mouse models of Alzheimer’s disease. One month later in Neuron, the team showed in that longer-term regimens of 40Hz light (three to six weeks versus one week) change gene expression in neurons and microglia, prevent synapse and neuron loss, and improve learning and memory.
The novel yet simple light-based therapy for Alzheimer’s disease that Tsai’s lab first developed in 2016 is now in clinical trials at the Massachusetts Institute of Technology. While many members of the group continue to work to better understand several key mechanistic questions underlying the measured benefits of sensory gamma rhythm stimulation — including the means by which glial cells as well as neurons change their gene expression and activity as a result — other members of the team have begun a program of human clinical studies studying safety and efficacy in healthy people and in people with early Alzheimer’s or cognitive impairment.
For her groundbreaking research and commitment to mentoring women of all backgrounds and career levels, Tsai received the Mika Salpeter Lifetime Achievement Award in 2016. Here, she talks about creativity in research, as well as diversity and mentoring as hallmarks of a strong lab.
This interview was originally published in 2017.
Access to the full article is available to SfN members.
Neuronline is a benefit of SfN membership. Renew your membership now to make sure you don’t lose access.
Speaker






